New stock dark market | LiBang Medicine-B (09637.HK) rose 76.99% in the early trading, earning 1740 Hong Kong dollars on one hand.

According to the Wise Financial APP, the Hong Kong stock "the first stock of innovative drugs for kidney disease" Libang Medicine-B (09637.HK) will be listed on the Hong Kong Stock Exchange on June 29 (Monday). In the dark market trading today, as of the time of publication, the dark market trading of Livermore Securities shows a price of 40 Hong Kong dollars, which is a 76.99% increase from the issue price of 22.60 Hong Kong dollars. With 100 shares per hand, excluding handling fees, each hand earns 1740 Hong Kong dollars on the book.